Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
- PMID: 29345697
- PMCID: PMC5769264
- DOI: 10.4103/iju.IJU_341_17
Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
Conflict of interest statement
Conflicts of interest: There are no conflicts of interest.
Comment on
-
Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer.Indian J Urol. 2017 Oct-Dec;33(4):304-309. doi: 10.4103/iju.IJU_8_17. Indian J Urol. 2017. PMID: 29021655 Free PMC article.
References
-
- Kamel MH, Littlejohn N, Cox M, Eltahawy EA, Davis R. Post-chemotherapy robotic retroperitoneal lymph node dissection: Institutional experience. J Endourol. 2016;30:510–9. - PubMed
-
- Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: Review of the M. D. Anderson experience. J Urol. 2006;176:1463–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
